We also observed a distinct immune architecture between synchronous and metachronous LM: in metachronous LM, CD1a+ cell density was higher in OM and CD208+ cell density was higher in IM and PT than in synchronous lesions (p < 0.05). The gene discussed is CD1A; the disease is ocular melanoma.